Group B Streptococcus surface proteins as major determinants for meningeal tropism

Current Opinion in Microbiology

Volumn 15, Issue 1, 2012, Pages 44-49

  Tazi, Asmaa ^a,b,c   Bellais, Samuel ^a,b   Tardieux, Isabelle ^a,b   Dramsi, Shaynoor ^d   Trieu Cuot, Patrick ^d   Poyart, Claire ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c Centre National de Référence des Streptocoques Hôpital Cochin ^*  (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; MEMBRANE PROTEIN;

BACTERIAL VIRULENCE; BRAIN BLOOD FLOW; CELL ADHESION; HUMAN; MENINGITIS; MOLECULAR CLONING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; STREPTOCOCCUS AGALACTIAE; TROPISM;

BLOOD-BRAIN BARRIER; HUMANS; MEMBRANE PROTEINS; MENINGES; STREPTOCOCCUS AGALACTIAE; TROPISM; VIRULENCE FACTORS;

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 84856096805     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2011.12.002     Document Type: Review

References (39)

1. Edwards MS, Nizet V: Group B streptococcal infections. In Infectious diseases of the fetus and newborn infant, edn 7. Edited by Wilson CB, Nizet V, Maldonado MA. Elsevier; 2011:419-469. [Remington JS, Klein JO (Series Editor).].
2. Phares C.R., Lynfield R., Farley M.M., Mohle-Boetani J., Harrison L.H., Petit S., Craig A.S., Schaffner W., Zansky S.M., Gershman K., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299:2056-2065.
3. Skoff T.H., Farley M.M., Petit S., Craig A.S., Schaffner W., Gershman K., Harrison L.H., Lynfield R., Mohle-Boetani J., Zansky S., et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009, 49:85-92.
4. Thigpen M.C., Whitney C.G., Messonnier N.E., Zell E.R., Lynfield R., Hadler J.L., Harrison L.H., Farley M.M., Reingold A., Bennett N.M., et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
5. Poyart C., Reglier-Poupet H., Tazi A., Billoet A., Dmytruk N., Bidet P., Bingen E., Raymond J., Trieu-Cuot P. Invasive group B streptococcal infections in infants, France. Emerg Infect Dis 2008, 14:1647-1649.
6. Tazi A., Disson O., Bellais S., Bouaboud A., Dmytruk N., Dramsi S., Mistou M.Y., Khun H., Mechler C., Tardieux I., et al. The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med 2010, 207:2313-2322.
7. Ferrieri P., Burke B., Nelson J. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun 1980, 27:1023-1032.
8. Pardridge W.M. Blood-brain barrier biology and methodology. J Neurovirol 1999, 5:556-569.
9. Join-Lambert O., Morand P.C., Carbonnelle E., Coureuil M., Bille E., Bourdoulous S., Nassif X. Mechanisms of meningeal invasion by a bacterial extracellular pathogen, the example of Neisseria meningitidis. Prog Neurobiol 2010, 91:130-139.
10. Musser J.M., Mattingly S.J., Quentin R., Goudeau A., Selander R.K. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci USA 1989, 86:4731-4735.
11. Brochet M., Couve E., Zouine M., Vallaeys T., Rusniok C., Lamy M.C., Buchrieser C., Trieu-Cuot P., Kunst F., Poyart C., et al. Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes Infect 2006, 8:1227-1243.
12. Jones N., Bohnsack J.F., Takahashi S., Oliver K.A., Chan M.S., Kunst F., Glaser P., Rusniok C., Crook D.W., Harding R.M., et al. Multilocus sequence typing system for group B Streptococcus. J Clin Microbiol 2003, 41:2530-2536.
13. Sorensen U.B., Poulsen K., Ghezzo C., Margarit I., Kilian M. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. MBio 2010, 1:1-9.
14. Tettelin H., Masignani V., Cieslewicz M.J., Donati C., Medini D., Ward N.L., Angiuoli S.V., Crabtree J., Jones A.L., Durkin A.S., et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial " pan-genome" Proc Natl Acad Sci USA 2005, 102:13950-13955.
15. Bohnsack J.F., Whiting A., Gottschalk M., Dunn D.M., Weiss R., Azimi P.H., Philips J.B., Weisman L.E., Rhoads G.G., Lin F.Y. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J Clin Microbiol 2008, 46:1285-1291.
16. Brochet M., Rusniok C., Couve E., Dramsi S., Poyart C., Trieu-Cuot P., Kunst F., Glaser P. Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc Natl Acad Sci USA 2008, 105:15961-15966.
17. Sheen T.R., Jimenez A., Wang N.Y., Banerjee A., van Sorge N.M., Doran K.S. Serine rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol 2011, 193:6834-6842.
18. van Sorge N.M., Quach D., Gurney M.A., Sullam P.M., Nizet V., Doran K.S. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis 2009, 199:1479-1487.
19. Seifert K.N., Adderson E.E., Whiting A.A., Bohnsack J.F., Crowley P.J., Brady L.J. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 2006, 152:1029-1040.
20. Mistou M.Y., Dramsi S., Brega S., Poyart C., Trieu-Cuot P. Molecular dissection of the secA2 locus of group B Streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence. J Bacteriol 2009, 191:4195-4206.
21. Dramsi S., Caliot E., Bonne I., Guadagnini S., Prevost M.C., Kojadinovic M., Lalioui L., Poyart C., Trieu-Cuot P. Assembly and role of pili in group B streptococci. Mol Microbiol 2006, 60:1401-1413.
22. Rosini R., Rinaudo C.D., Soriani M., Lauer P., Mora M., Maione D., Taddei A., Santi I., Ghezzo C., Brettoni C., et al. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Mol Microbiol 2006, 61:126-141.
23. Adderson E.E., Takahashi S., Wang Y., Armstrong J., Miller D.V., Bohnsack J.F. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect Immun 2003, 71:6857-6863.
24. Margarit I., Rinaudo C.D., Galeotti C.L., Maione D., Ghezzo C., Buttazzoni E., Rosini R., Runci Y., Mora M., Buccato S., et al. Preventing bacterial infections with pilus-based vaccines: the group B Streptococcus paradigm. J Infect Dis 2009, 199:108-115.
25. Konto-Ghiorghi Y., Mairey E., Mallet A., Dumenil G., Caliot E., Trieu-Cuot P., Dramsi S. Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog 2009, 5:e1000422.
26. Maisey H.C., Hensler M., Nizet V., Doran K.S. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol 2007, 189:1464-1467.
27. Banerjee A., Kim B.J., Carmona E.M., Cutting A.S., Gurney M.A., Carlos C., Feuer R., Prasadarao N.V., Doran K.S. Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat Commun 2011, 2:462.
28. Nizet V., Kim K.S., Stins M., Jonas M., Chi E.Y., Nguyen D., Rubens C.E. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 1997, 65:5074-5081.
29. Cabodi S., Di Stefano P., Leal Mdel P., Tinnirello A., Bisaro B., Morello V., Damiano L., Aramu S., Repetto D., Tornillo G., et al. Integrins and signal transduction. Adv Exp Med Biol 2010, 674:43-54.
30. Shin S., Paul-Satyaseela M., Lee J.S., Romer L.H., Kim K.S. Focal adhesion kinase is involved in type III group B streptococcal invasion of human brain microvascular endothelial cells. Microb Pathog 2006, 41:168-173.
31. Michel J.L., Madoff L.C., Olson K., Kling D.E., Kasper D.L., Ausubel F.M. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci USA 1992, 89:10060-10064.
32. Baron M.J., Bolduc G.R., Goldberg M.B., Auperin T.C., Madoff L.C. Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J Biol Chem 2004, 279:24714-24723.
33. Bolduc G.R., Baron M.J., Gravekamp C., Lachenauer C.S., Madoff L.C. The alpha C protein mediates internalization of group B Streptococcus within human cervical epithelial cells. Cell Microbiol 2002, 4:751-758.
34. Chang Y.C., Wang Z., Flax L.A., Xu D., Esko J.D., Nizet V., Baron M.J. Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog 2011, 7:e1002082.
35. Doran K.S., Engelson E.J., Khosravi A., Maisey H.C., Fedtke I., Equils O., Michelsen K.S., Arditi M., Peschel A., Nizet V. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest 2005, 115:2499-2507.
36. Pietrocola G., Schubert A., Visai L., Torti M., Fitzgerald J.R., Foster T.J., Reinscheid D.J., Speziale P. FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. Blood 2005, 105:1052-1059.
37. Schubert A., Zakikhany K., Pietrocola G., Meinke A., Speziale P., Eikmanns B.J., Reinscheid D.J. The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect Immun 2004, 72:6197-6205.
38. Tenenbaum T., Bloier C., Adam R., Reinscheid D.J., Schroten H. Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae. Infect Immun 2005, 73:4404-4409.
39. Al Safadi R., Mereghetti L., Salloum M., Lartigue M.F., Virlogeux-Payant I., Quentin R., Rosenau A. Two-component system RgfA/C activates the fbsB gene encoding major fibrinogen-binding protein in highly virulent CC17 clone group B Streptococcus. PLoS One 2011, 6:e14658.